Unknown

Dataset Information

0

Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

ABSTRACT: To determine the site and mechanism of suppression by regulatory T (Treg) cells, we investigated their migration and function in an islet allograft model. Treg cells first migrated from blood to the inflamed allograft where they were essential for the suppression of alloimmunity. This process was dependent on the chemokine receptors CCR2, CCR4, and CCR5 and P- and E-selectin ligands. In the allograft, Treg cells were activated and subsequently migrated to the draining lymph nodes (dLNs) in a CCR2, CCR5, and CCR7 fashion; this movement was essential for optimal suppression. Treg cells inhibited dendritic cell migration in a TGF-beta and IL-10 dependent fashion and suppressed antigen-specific T effector cell migration, accumulation, and proliferation in dLNs and allografts. These results showed that sequential migration from blood to the target tissue and to dLNs is required for Treg cells to differentiate and execute fully their suppressive function.

SUBMITTER: Zhang N 

PROVIDER: S-EPMC2737741 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Zhang Nan N   Schröppel Bernd B   Lal Girdhari G   Jakubzick Claudia C   Mao Xia X   Chen Dan D   Yin Na N   Jessberger Rolf R   Ochando Jordi C JC   Ding Yaozhong Y   Bromberg Jonathan S JS  

Immunity 20090301 3

To determine the site and mechanism of suppression by regulatory T (Treg) cells, we investigated their migration and function in an islet allograft model. Treg cells first migrated from blood to the inflamed allograft where they were essential for the suppression of alloimmunity. This process was dependent on the chemokine receptors CCR2, CCR4, and CCR5 and P- and E-selectin ligands. In the allograft, Treg cells were activated and subsequently migrated to the draining lymph nodes (dLNs) in a CCR  ...[more]

Similar Datasets

Unknown VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes.
| S-EPMC2200913 | biostudies-literature
Unknown LIGHT regulates inflamed draining lymph node hypertrophy.
| S-EPMC3110546 | biostudies-literature
Unknown TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
| S-EPMC6492974 | biostudies-literature
Unknown Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth.
| S-EPMC4507466 | biostudies-literature
Unknown Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin.
| S-EPMC3910256 | biostudies-literature
Unknown Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth.
| S-EPMC8748771 | biostudies-literature
Unknown Melanoma growth effects on molecular clearance from tumors and biodistribution into systemic tissues versus draining lymph nodes.
| S-EPMC4724472 | biostudies-literature
Unknown Mechanisms of Tumor-Induced Lymphovascular Niche Formation in Draining Lymph Nodes.
| S-EPMC6315107 | biostudies-literature
Unknown TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues.
| S-EPMC1939810 | biostudies-literature
Unknown Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes.
| S-EPMC2928294 | biostudies-literature